Skip to content

Translating Evidence Based Developmental Screening Into Pediatric Primary Care

Translating Evidence Based Developmental Screening Into Pediatric Primary Care ( Aims 2 and 3 )

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00844246
Acronym
TEDS
Enrollment
2314
Registered
2009-02-16
Start date
2008-11-30
Completion date
2010-10-31
Last updated
2011-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Delays

Keywords

Developmental delays, Early intervention services

Brief summary

The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the American Academy of Pediatrics (AAP's) recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical developmental periods in childhood, namely at 9, 18, 24 and 30 months of age.

Detailed description

The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the AAP's recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical developmental periods in childhood, namely at 9, 18, 24 and 30 months of age. The study will also examine its acceptance by pediatric practices, its adoption and adaptation in urban pediatric practices, and the effectiveness of a developmental screening protocol that conforms to the AAP and Maternal and Child Health Bureau (MCHB) recommendations compared with that of developmental surveillance alone.

Interventions

OTHERDevelopmental screening using ASQ and MCHAT

In the SRS intervention arm subjects will complete developmental screening tools with a school readiness specialist at their 9, 18, 24 and 30 month well child visits and then complete their well child visit with their primary care clinician to discuss the results.

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Children's Hospital of Philadelphia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 30 Months
Healthy volunteers
Yes

Inclusion criteria

1. Age birth to 30 months of age by the start of the intervention phase. 2. Child's Primary Care Physician has consented to participate in the study 3. Parental/guardian permission (informed consent).

Exclusion criteria

1. Premature Infants (less than 36 weeks of gestation) 2. Children with prior identified developmental delay. 3. Children with major congenital anomalies/genetic disorders 4. Children placed in foster care

Design outcomes

Primary

MeasureTime frame
The primary outcome measure for this study will be the percentage of children enrolled in the study who are identified as having a developmental delay.We assessed this between June to October 2010

Secondary

MeasureTime frame
Percentage of children in the study who are referred to Early Intervention ServicesWe assessed this in June 2010
Percentage of children in the study who enroll in Early Intervention ServicesWe will assess this between June to October 2010
Percent of parents enrolled in the study who report as satisfied with the interventionWe assessed this between March and September 2010
Percent of providers enrolled in the study who report as satisfied with the intervention.We will assess this between March and September 2010

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026